Federal policy decisions have profound implications for IDN pharmacy operations, reimbursement models, and strategic planning. From 340B program integrity to comprehensive legislative packages, rural hospital support, and FDA regulatory changes, the policy landscape continues to evolve rapidly. In this session, hear from a healthcare attorney who will break down the latest developments from Washington and translate complex policy changes into actionable insights for pharmacy and supply chain leaders.

Gain clarity on how recent and pending federal actions may impact your organization’s pharmacy operations, financial performance, and compliance obligations.

Learning Objectives:
1. Interpret current legislative and regulatory developments impacting the 340B Program and their implications for eligible entities.
2. Assess how comprehensive healthcare legislation and rural hospital initiatives may impact IDN pharmacy strategy and operations.
3. Recognize recent FDA policy changes and enforcement priorities that impact drug access, supply chain management, and compliance requirements.
4. Develop proactive strategies to navigate regulatory uncertainty and position your organization for success amid evolving federal healthcare policy.